Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study.

Abtahi S, Pajouheshnia R, Durán CE, Riera-Arnau J, Gamba M, Alsina E, Hoxhaj V, Andersen M, Bartolini C, Kristiansen SB, Brown J, Hallgreen CE, Garcia-Poza P, Gardarsdottir H, Gini R, Girardi A, Holthuis E, Huerta C, Ibánez L, Limoncella G, Martín-Pérez M, Paoletti O, Roberto G, Souverein P, Swart KMA, Wing K, Sturkenboom M, Klungel O.

Open source

DOI: 10.1007/s40264-023-01314-3
Published: 2023-06-09
Container: Drug Saf
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40264-023-01314-3,
  title = {Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study.},
  author = {Abtahi S and  Pajouheshnia R and  Durán CE and  Riera-Arnau J and  Gamba M and  Alsina E and  Hoxhaj V and  Andersen M and  Bartolini C and  Kristiansen SB and  Brown J and  Hallgreen CE and  Garcia-Poza P and  Gardarsdottir H and  Gini R and  Girardi A and  Holthuis E and  Huerta C and  Ibánez L and  Limoncella G and  Martín-Pérez M and  Paoletti O and  Roberto G and  Souverein P and  Swart KMA and  Wing K and  Sturkenboom M and  Klungel O.},
  year = {2023},
  journal = {Drug Saf},
  doi = {10.1007/s40264-023-01314-3},
  url = {https://doi.org/10.1007/s40264-023-01314-3}
}

RIS

TY  - JOUR
TI  - Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study.
AU  - Abtahi S
AU  -  Pajouheshnia R
AU  -  Durán CE
AU  -  Riera-Arnau J
AU  -  Gamba M
AU  -  Alsina E
AU  -  Hoxhaj V
AU  -  Andersen M
AU  -  Bartolini C
AU  -  Kristiansen SB
AU  -  Brown J
AU  -  Hallgreen CE
AU  -  Garcia-Poza P
AU  -  Gardarsdottir H
AU  -  Gini R
AU  -  Girardi A
AU  -  Holthuis E
AU  -  Huerta C
AU  -  Ibánez L
AU  -  Limoncella G
AU  -  Martín-Pérez M
AU  -  Paoletti O
AU  -  Roberto G
AU  -  Souverein P
AU  -  Swart KMA
AU  -  Wing K
AU  -  Sturkenboom M
AU  -  Klungel O.
PY  - 2023
JO  - Drug Saf
DO  - 10.1007/s40264-023-01314-3
UR  - https://doi.org/10.1007/s40264-023-01314-3
ER  -

APA

S, A., R, P., CE, D., J, R., M, G., E, A., V, H., M, A., C, B., SB, K., J, B., CE, H., P, G., H, G., R, G., A, G., E, H., C, H., L, I., G, L., M, M., O, P., G, R., P, S., KMA, S., K, W., M, S., & O., K. (2023). Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study.. Drug Saf. https://doi.org/10.1007/s40264-023-01314-3

Source records

europe-pmc · retrieved 2026-09-25T20:02:04.999Z